Sequenom Inc. to Provide Quantitative Gene Expression Services to the Immune Tolerance Network

SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM) today announced that it will provide quantitative gene expression (QGE) services to the Immune Tolerance Network (ITN), a collaborative research organization that solicits, develops, implements and assesses clinical strategies and biological assays for the purposes of inducing, maintaining and monitoring tolerance in humans for kidney, liver and islet transplantation, autoimmune diseases, and allergy and asthma. Financial terms of the contract were not disclosed.

MORE ON THIS TOPIC